Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.
Gao L, Zhang Y, Sterling K, Song W. · 2022
Read Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. by Gao L, Zhang Y, Sterling K, Song W. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8796548.txt.
Description
Gao and co-authors review brain-derived neurotrophic factor, or BDNF, in Alzheimer disease and its drug potential. Synapse faults are a core trait of the disease and grow as it advances. BDNF supports the plasticity that learning and memory need. Its loss links to amyloid buildup, tau changes, inflammation, and neuron death.
How faulty BDNF signaling drives the disease is still not settled. The review first maps the gene's structure and the factors that control it. It then weighs BDNF as a diagnostic marker in patients. Therapies that target the factor form the last part. The authors see real promise but clear gaps in mechanism.
Catalog record
| CREATOR | Gao L, Zhang Y, Sterling K, Song W. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 208 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |